LONDON (Reuters) - AstraZeneca Plc has settled a U.S. patent dispute with India's Ranbaxy Laboratories Ltd over its top-selling ulcer pill Nexium, securing future sales of the product and boosting its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results